Skip to main content

Advertisement

SpringerLink
Log in

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

Estrogen is involved in both normal mammary development and in breast carcinogenesis. A family history of disease and exposure to estrogen are major risk factors for developing breast cancer. Estrogen exerts its biological effects through binding to the estrogen receptors, estrogen receptor alpha (ESR1) and the more recently discovered estrogen receptor beta (ESR2). Genetic variation in genes involved in estrogen biosynthesis, metabolism and signal transduction have been suggested to play a role in breast cancer risk. We therefore tested the hypothesis that common genetic variants of the ESR2 gene may be associated with increased risk for breast cancer and this risk may vary between breast cancer groups. We investigated three common ESR2 polymorphisms, rs1256049 (G1082A), rs4986938 (G1730A) and rs928554 (Cx+56 A→G) for association to breast cancer risk. A total of 723 breast cancer cases and 480 controls were included in the study. Of the breast cancer cases, 323 were sporadic and 400 were familial, the familial cases were further divided into familial high-risk and familial low-risk breast cancer cases. We found no overall statistically significant association for any of the single polymorphisms studied. Haplotype analysis suggested one haplotype associated with increased risk in sporadic breast cancer patients (OR = 3.0, p = 0.03). Further analysis is needed to elucidate the role of estrogen receptor beta in breast cancer susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding (1994) ArticleTitleA strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66–71 Occurrence Handle7545954

    PubMed  Google Scholar 

  2. R Wooster SL Neuhausen J Mangion Y Quirk D Ford N Collins K Nguyen S Seal T Tran D Averill (1994) ArticleTitleLocalization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13 Science 265 2088–2090 Occurrence Handle8091231

    PubMed  Google Scholar 

  3. PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder (2002) ArticleTitlePolygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33–36 Occurrence Handle10.1038/ng853 Occurrence Handle11984562

    Article  PubMed  Google Scholar 

  4. AM Martin BL Weber (2000) ArticleTitleGenetic and hormonal risk factors in breast cancer J Natl Cancer Inst 92 1126–1135 Occurrence Handle10.1093/jnci/92.14.1126 Occurrence Handle10904085

    Article  PubMed  Google Scholar 

  5. S Green P Walter V Kumar A Krust JM Bornert P Argos P Chambon (1986) ArticleTitleHuman oestrogen receptor cDNA: sequence, expression and homology to v-erb-A Nature 320 134–139 Occurrence Handle10.1038/320134a0 Occurrence Handle3754034

    Article  PubMed  Google Scholar 

  6. GL Greene P Gilna M Waterfield A Baker Y Hort J Shine (1986) ArticleTitleSequence and expression of human estrogen receptor complementary DNA Science 231 1150–1154 Occurrence Handle3753802

    PubMed  Google Scholar 

  7. S Mosselman J Polman R Dijkema (1996) ArticleTitleER beta: identification and characterization of a novel human estrogen receptor FEBS Lett 392 49–53 Occurrence Handle10.1016/0014-5793(96)00782-X Occurrence Handle8769313

    Article  PubMed  Google Scholar 

  8. GG Kuiper E Enmark M Pelto-Huikko S Nilsson JA Gustafsson (1996) ArticleTitleCloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 5925–5930 Occurrence Handle10.1073/pnas.93.12.5925 Occurrence Handle8650195

    Article  PubMed  Google Scholar 

  9. QX Zhang A Borg SA Fuqua (1993) ArticleTitleAn exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer Cancer Res 53 5882–5884 Occurrence Handle8261397

    PubMed  Google Scholar 

  10. S Inoue S Hoshino H Miyoshi M Akishita T Hosoi H Orimo Y Ouchi (1996) ArticleTitleIdentification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells Biochem Biophys Res Commun 219 766–772 Occurrence Handle10.1006/bbrc.1996.0308 Occurrence Handle8645255

    Article  PubMed  Google Scholar 

  11. S Ogawa S Inoue T Watanabe A Orimo T Hosoi Y Ouchi M Muramatsu (1998) ArticleTitleMolecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human Nucleic Acids Res 26 3505–3512 Occurrence Handle10.1093/nar/26.15.3505 Occurrence Handle9671811

    Article  PubMed  Google Scholar 

  12. S Ogawa S Inoue T Watanabe H Hiroi A Orimo T Hosoi Y Ouchi M Muramatsu (1998) ArticleTitleThe complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro Biochem Biophys Res Commun 243 122–126 Occurrence Handle10.1006/bbrc.1997.7893 Occurrence Handle9473491

    Article  PubMed  Google Scholar 

  13. E Leygue H Dotzlaw PH Watson LC Murphy (1999) ArticleTitleExpression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue Cancer Res 59 1175–1179 Occurrence Handle10096542

    PubMed  Google Scholar 

  14. C Palmieri GJ Cheng S Saji M Zelada-Hedman A Warri Z Weihua S Noorden ParticleVan T Wahlstrom RC Coombes M Warner (2002) ArticleTitleEstrogen receptor beta in breast cancer Endocr Relat Cancer 9 1–13 Occurrence Handle10.1677/erc.0.0090001 Occurrence Handle11914179

    Article  PubMed  Google Scholar 

  15. K Iwao Y Miyoshi C Egawa N Ikeda S Noguchi (2000) ArticleTitleQuantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers Int J Cancer 88 733–736 Occurrence Handle10.1002/1097-0215(20001201)88:5<733::AID-IJC8>3.0.CO;2-M Occurrence Handle11072241

    Article  PubMed  Google Scholar 

  16. C Zhao EW Lam A Sunters E Enmark MT Bella ParticleDe RC Coombes JA Gustafsson K Dahlman-Wright (2003) ArticleTitleExpression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 7600–7606 Occurrence Handle10.1038/sj.onc.1207100 Occurrence Handle14576822

    Article  PubMed  Google Scholar 

  17. E Leygue H Dotzlaw PH Watson LC Murphy (1998) ArticleTitleAltered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis Cancer Res 58 3197–3201 Occurrence Handle9699641

    PubMed  Google Scholar 

  18. AM Dunning CS Healey PD Pharoah MD Teare BA Ponder DF Easton (1999) ArticleTitleA systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 8 843–854 Occurrence Handle10548311

    PubMed  Google Scholar 

  19. A Forsti C Zhao E Israelsson K Dahlman-Wright JA Gustafsson K Hemminki (2003) ArticleTitlePolymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association Breast Cancer Res Treat 79 409–413 Occurrence Handle10.1023/A:1024020609833 Occurrence Handle12846425

    Article  PubMed  Google Scholar 

  20. SL Zheng W Zheng BL Chang XO Shu Q Cai H Yu Q Dai J Xu YT Gao (2003) ArticleTitleJoint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women Cancer Res 63 7624–7629 Occurrence Handle14633679

    PubMed  Google Scholar 

  21. B Gold F Kalush J Bergeron K Scott N Mitra K Wilson N Ellis H Huang M Chen R Lippert (2004) ArticleTitleEstrogen receptor genotypes and haplotypes associated with breast cancer risk Cancer Res 64 8891–8900 Occurrence Handle10.1158/0008-5472.CAN-04-1256 Occurrence Handle15604249

    Article  PubMed  Google Scholar 

  22. K Rosenkranz A Hinney A Ziegler H Hermann M Fichter H Mayer W Siegfried JK Young H Remschmidt J Hebebrand (1998) ArticleTitleSystematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants J Clin Endocrinol Metab 83 4524–4527 Occurrence Handle10.1210/jc.83.12.4524 Occurrence Handle9851804

    Article  PubMed  Google Scholar 

  23. M Nilsson S Naessen I Dahlman A Linden Hirschberg JA Gustafsson K Dahlman-Wright (2004) ArticleTitleAssociation of estrogen receptor beta gene polymorphisms with bulimic disease in women Mol Psychiatry 9 28–34 Occurrence Handle10.1038/sj.mp.4001402 Occurrence Handle14699439

    Article  PubMed  Google Scholar 

  24. EB Claus JM Schildkraut WD Thompson NJ Risch (1996) ArticleTitleThe genetic attributable risk of breast and ovarian cancer Cancer 77 2318–2324 Occurrence Handle10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z Occurrence Handle8635102

    Article  PubMed  Google Scholar 

  25. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill (1989) ArticleTitleProjecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879–1886 Occurrence Handle2593165

    PubMed  Google Scholar 

  26. S Margolin B Werelius T Fornander A Lindblom (2004) ArticleTitleBRCA1 mutations in a population-based study of breast cancer in Stockholm County Genet Test 8 127–132 Occurrence Handle15345109

    PubMed  Google Scholar 

  27. JC Barrett B Fry J Maller MJ Daly (2005) ArticleTitleHaploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263–265 Occurrence Handle10.1093/bioinformatics/bth457 Occurrence Handle15297300

    Article  PubMed  Google Scholar 

  28. F Dudbridge (2003) ArticleTitlePedigree disequilibrium tests for multilocus haplotypes Genet Epidemiol 25 115–121 Occurrence Handle10.1002/gepi.10252 Occurrence Handle12916020

    Article  PubMed  Google Scholar 

  29. SB Gabriel SF Schaffner H Nguyen JM Moore J Roy B Blumenstiel J Higgins M DeFelice A Lochner M Faggart (2002) ArticleTitleThe structure of haplotype blocks in the human genome Science 296 2225–2229 Occurrence Handle10.1126/science.1069424 Occurrence Handle12029063

    Article  PubMed  Google Scholar 

  30. S Inoue S Ogawa K Horie S Hoshino W Goto T Hosoi O Tsutsumi M Muramatsu Y Ouchi (2000) ArticleTitleAn estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta Biochem Biophys Res Commun 279 814–819 Occurrence Handle10.1006/bbrc.2000.4010 Occurrence Handle11162434

    Article  PubMed  Google Scholar 

  31. D Tong E Schuster M Seifert K Czerwenka S Leodolte R Zeillinger (2002) ArticleTitleExpression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines Breast Cancer Res Treat 71 249–255 Occurrence Handle10.1023/A:1014465916473 Occurrence Handle12002343

    Article  PubMed  Google Scholar 

  32. Y Omoto S Kobayashi S Inoue S Ogawa T Toyama H Yamashita M Muramatsu JA Gustafsson H Iwase (2002) ArticleTitleEvaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers Eur J Cancer 38 380–386 Occurrence Handle10.1016/S0959-8049(01)00383-5 Occurrence Handle11818203

    Article  PubMed  Google Scholar 

  33. I Poola J Abraham A Liu (2002) ArticleTitleEstrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis J Steroid Biochem Mol Biol 82 169–179 Occurrence Handle10.1016/S0960-0760(02)00185-1 Occurrence Handle12477483

    Article  PubMed  Google Scholar 

  34. C Palmieri S Saji H Sakaguchi G Cheng A Sunters MJ O’Hare M Warner JA Gustafsson RC Coombes EW Lam (2004) ArticleTitleThe expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts J Mol Endocrinol 33 35–50 Occurrence Handle10.1677/jme.0.0330035 Occurrence Handle15291741

    Article  PubMed  Google Scholar 

  35. I Girault C Andrieu S Tozlu F Spyratos I Bieche R Lidereau (2004) ArticleTitleAltered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma Cancer Lett 215 101–112 Occurrence Handle10.1016/j.canlet.2004.05.006 Occurrence Handle15374639

    Article  PubMed  Google Scholar 

  36. C Sundarrajan WX Liao AC Roy SC Ng (2001) ArticleTitleAssociation between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders J Clin Endocrinol Metab 86 135–139 Occurrence Handle10.1210/jc.86.1.135 Occurrence Handle11231990

    Article  PubMed  Google Scholar 

  37. S Ogawa T Hosoi M Shiraki H Orimo M Emi M Muramatsu Y Ouchi S Inoue (2000) ArticleTitleAssociation of estrogen receptor beta gene polymorphism with bone mineral density Biochem Biophys Res Commun 269 537–541 Occurrence Handle10.1006/bbrc.2000.2285 Occurrence Handle10708589

    Article  PubMed  Google Scholar 

  38. Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, Vivo ID: Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States) Cancer Causes Control 15: 627–633, 2004

    Google Scholar 

  39. S Garte L Gaspari AK Alexandrie C Ambrosone H Autrup JL Autrup H Baranova L Bathum S Benhamou P Boffetta (2001) ArticleTitleMetabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 1239–1248 Occurrence Handle11751440

    PubMed  Google Scholar 

  40. K Hemminki A Forsti (2002) ArticleTitleProper controls for SNP studies? Carcinogenesis 23 1405–1406 Occurrence Handle10.1093/carcin/23.8.1405 Occurrence Handle12151361

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden

    Paula Maguire, Johanna Skoglund & Annika Lindblom

  2. Department of Oncology, Karolinska University Hospital, Södersjukhuset, Stockholm, Sweden

    Sara Margolin

  3. Department of Oncology, University Hospital, Linköping, Sweden

    Xiao-Feng Sun

  4. Department of Medical Nutrition, Karolinska Institute, Novum, Huddinge, Sweden

    Jan-Åke Gustafsson

  5. Department of Genetics, The Norwegian Radium Hospital, University of Oslo, Montebello, Oslo, Norway

    Anne-Lise Børresen-Dale

Authors
  1. Paula Maguire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Margolin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johanna Skoglund
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-Feng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jan-Åke Gustafsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anne-Lise Børresen-Dale
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Annika Lindblom
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annika Lindblom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maguire, P., Margolin, S., Skoglund, J. et al. Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer. Breast Cancer Res Treat 94, 145–152 (2005). https://doi.org/10.1007/s10549-005-7697-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-7697-7

Keywords

Search

Navigation